GlassScriptPhysician profile
Timothy A Torres
NPI 1932543816
$8,782.88
in general payments reported to CMS, 2019-2025
19 companies · $8,426 in 2025
The $8,426 reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $53.68 · 2021: $13.00 · 2022: $91.51 · 2023: $23.43 · 2024: $42.47 · 2025: $8,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,336 · Travel and Lodging: $4,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,336.48 |
| Travel and Lodging | $4,155.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,409.33 | 2025 | Proclaim, Eterna, Durata |
| Boston Scientific Corporation | $1,013.28 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Si-Bone, INC. | $993.11 | 2025 | |
| Medtronic, INC. | $861.40 | 2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Biotronik Nro, INC. | $534.22 | 2025 | Prospera |
| Nalu Medical, INC. | $260.39 | 2025 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $180.54 | 2025 | Qutenza |
| Avanos Medical | $133.85 | 2025 | Coolief Cooled Radiofrequency |
| Merck Sharp & Dohme LLC | $92.19 | 2019-2023 | Bridion |
| Acacia Pharma INC | $70.45 | 2022 | |
| Mallinckrodt Enterprises LLC | $56.74 | 2019 | |
| Mallinckrodt Hospital Products INC. | $40.60 | 2020 | |
| Eagle Pharmaceuticals, INC. | $28.23 | 2024 | |
| Lundbeck LLC | $26.25 | 2025 | Vyepti |
| Atricure, INC. | $21.06 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $20.29 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.24 | 2024 | |
| Mml US, INC. | $13.63 | 2025 | Reactiv8 |
| Chiesi USA, INC. | $13.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.